“Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach”, AJD, vol. 25, no. 2, pp. 6–20, Nov. 2025, doi: 10.59793/j8y5zv46.